Loading...

CBD Life Sciences Inc.

CBDL•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.00
$0.00(40.00%)
U.S. Market opens in 2h 47m

CBD Life Sciences Inc. (CBDL) Stock Overview

Explore CBD Life Sciences Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap563.1K
P/E Ratio-204.92
EPS (TTM)$-0.01
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$0.00
3 Months$0.00
1 Year Target$2.4672533260762354e+54

CBDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CBD Life Sciences Inc. (CBDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 58.10, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.4672533260762354e+54.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -204.92 and a market capitalization of 563.1K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
40.00%
5-Day Change
40.00%
1-Month Change
250.00%
3-Month Change
125.81%
6-Month Change
75.00%
Year-to-Date (YTD) Change
75.00%
1-Year Change
-12.50%
3-Year Change
-100.00%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://lbcbioscienceinc.com
480 410 6780
10855 N 116th Street, Scottsdale, AZ, 85259

Company Facts

3 Employees
IPO DateSep 11, 2009
CountryUS
Actively Trading

Frequently Asked Questions